(Q30387832)

21 June 2017

1 reference

title

Targeting pandemic influenza: a primer on influenza antivirals and drug resistance (English)

1 reference

21 June 2017

0 references

Ronald B Moss

1

1 reference

21 June 2017

Richard T Davey

series ordinal

2

1 reference

21 June 2017

Roy T Steigbigel

series ordinal

3

1 reference

21 June 2017

Fang Fang

series ordinal

4

1 reference

21 June 2017

language of work or name

English

0 references

publication date

7 April 2010

1 reference

Journal of Antimicrobial Chemotherapy

21 June 2017

1 reference

21 June 2017

65

1 reference

21 June 2017

1086-1093

1 reference

21 June 2017

6

1 reference

The persistent legacy of the 1918 influenza virus

21 June 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Historical perspective--Emergence of influenza A (H1N1) viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Implications of the emergence of a novel H1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

The 2009 H1N1 influenza outbreak in its historical context.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Controlling influenza virus replication by inhibiting its proton channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Emergence of amantadine-resistant influenza A viruses: epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

The evolution of influenza resistance and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Oseltamivir resistance--disabling our influenza defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Global transmission of oseltamivir-resistant influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

The potential impact of neuraminidase inhibitor resistant influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Zanamivir-resistant influenza viruses with a novel neuraminidase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

H1N1 pneumonitis treated with intravenous zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ100

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ100

1 reference

21 June 2017

1 reference